- Home
- TCBX vs TMCI Comparison
TCBX vs TMCI Comparison
Compare TCBX & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- TMCI
- Stock Information
- Founded
- TCBX 2008
- TMCI 2014
- Country
- TCBX United States
- TMCI United States
- Employees
- TCBX N/A
- TMCI N/A
- Industry
- TCBX Banks
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TCBX Finance
- TMCI Health Care
- Exchange
- TCBX Nasdaq
- TMCI Nasdaq
- Market Cap
- TCBX 454.9M
- TMCI 371.1M
- IPO Year
- TCBX 2021
- TMCI 2021
- Fundamental
- Price
- TCBX $35.42
- TMCI $6.00
- Analyst Decision
- TCBX Hold
- TMCI Hold
- Analyst Count
- TCBX 4
- TMCI 6
- Target Price
- TCBX $33.67
- TMCI $9.18
- AVG Volume (30 Days)
- TCBX 64.0K
- TMCI 315.1K
- Earning Date
- TCBX 07-23-2025
- TMCI 08-05-2025
- Dividend Yield
- TCBX N/A
- TMCI N/A
- EPS Growth
- TCBX 44.43
- TMCI N/A
- EPS
- TCBX 2.95
- TMCI N/A
- Revenue
- TCBX $172,270,000.00
- TMCI $210,819,000.00
- Revenue This Year
- TCBX $17.44
- TMCI $10.61
- Revenue Next Year
- TCBX $6.46
- TMCI $10.36
- P/E Ratio
- TCBX $11.95
- TMCI N/A
- Revenue Growth
- TCBX 17.40
- TMCI 7.54
- 52 Week Low
- TCBX $20.15
- TMCI $4.54
- 52 Week High
- TCBX $39.45
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- TCBX 69.59
- TMCI 49.03
- Support Level
- TCBX $34.36
- TMCI $6.04
- Resistance Level
- TCBX $35.66
- TMCI $6.44
- Average True Range (ATR)
- TCBX 1.07
- TMCI 0.31
- MACD
- TCBX 0.27
- TMCI 0.06
- Stochastic Oscillator
- TCBX 95.54
- TMCI 59.26
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.